Wave Life Sciences LTD Form 4 insider transactions

Director Heidi Wagner reports acquisition of Wave Life Sciences shares and options related to the 2024 Non-Employee Director Compensation Policy.

Director Ken Takanashi reports acquiring 16,115 ordinary shares and 32,230 share options in Wave Life Sciences Ltd.

Chandra Vargeese, Chief Technology Officer of Wave Life Sciences, exercised share options and acquired ordinary shares in a recent transaction.

Kyle Moran, CFO of Wave Life Sciences Ltd., reports the sale of 15,630 ordinary shares at an average price of $6.169 per share.